Simmons Center earns National Cancer Institute designation
UT Southwestern first site in N. America to test advanced cancer treatment system
Program identifies families at high risk for colorectal cancer
Synthetic compound may lead to drugs to fight pancreatic, lung cancer
Significantly more genetic mutations lead to colon cancer
New genetic screenings help identify colorectal cancers
More than 250,000 people in the U.S. are diagnosed with gastrointestinal cancer each year, which affects the digestive system and includes cancers of the esophagus, stomach, bowel, pancreas, liver, gall bladder, bile ducts, colon and rectum. Gastrointestinal cancers account for approximately 20 percent of all newly diagnosed cancers.
Using the significant contributions made by UT Southwestern Medical Center and others in the understanding, treatment and prevention of gastrointestinal cancers, we provide compassionate care in a setting that also features advanced therapies and surgical procedures often unavailable at other health-care facilities.
In addition, cancer-risk reduction is a major part of the gastrointestinal cancer program at UT Southwestern. Risk factors such as personal or family history of colorectal cancer or polyps should be taken into consideration when determining whether patients are candidates for preventive screenings or procedures that can reduce the risk for developing gastrointestinal cancer. UT Southwestern’s physicians have access to the latest technology, diagnostic procedures and treatments for gastrointestinal cancers, including:
Please visit the Health Library to learn more about gastrointestinal cancer.